Stabilisation of small proteins for their use as pharmacological scaffolds - Why knot?

Chimica Oggi

Volumn 25, Issue 3 SUPPL., 2007, Pages 37-39

  Boy, Regine Garcia ^a   Haberkorn, Uwe ^a   Mier, Walter ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); FUNGI;

EID: 34547214860     PISSN: 0392839X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Voet D, V.J., Pratt CW, Amino Acids, in Fundomentals of Biochemistry Ltd, J.W. Sons, Editor. 2005: New York.
2. US-FDA, Prialt (ziconotide intrathecal infusion), 2004, FDA, USA.
3. Trabi, M. and D.J. Craik, Circular proteins - no end in sight. Trends Biochem Sci, 2002. 27(3): p. 132-8.
4. McDonald, N.Q. and W.A. Hendrickson, A structural superfamily of growth factors containing a cystine knot motif. Cell, 1993. 73(3): p. 421-4.
5. Hernandez, J.F., et al., Squash trypsin inhibitors from Momordiea cochinehinensis exhibit an atypical macrocyclic structure. Biochemistry, 2000. 39(19): p. 5722-30.
6. Craik, D.J., et al., Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif, J Mol Biol, 1999. 294(5): p. 1327-36.
7. Sletten K, G.L., Some molecular properties of kalatapeptide B-1. A unterotonic polypeptide isolated from Oldenlandia affinis DC. Medd Nor Farm Selsk, 1973. 7-8: p. 69-82.
8. Christmann, A., et al., The cystine knot of a squash-type protease inhibitor as a structural scaffold for Escherichia coli cell surface display of conformationally constrained peptides. Protein Eng, 1999. 12(9): p. 797-806.
9. Miljanich, G.P., Ziconotide: neuronal calcium channel blocker for treating severe chronic pain. Curr Med Chem, 2004. 11 (23): p. 3029-40.
10. Saether, O., et al., Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1. Biochemistry, 1995. 34(13): p. 4147-58.
11. Schoepke T, H.A.M., Kraft R, Otto A, Hiller K, Haemolytisch aktive Komponenten aus Viola tricolor L und Viola arvensis Murray. Sci. Pharm., 1993. 61: p. 145-153.
12. Gustafson KR, S.R., Henderson LE, Parsons IC, Kashman Y, Cardellina JH, McMahon JB, Buckheit RW, Pannell LK, Bovd MR, Circulins A and B. Novel human immunodeficiency virus (HIV)-inhibitary macrocyclic peptides from the tropical tree Chassalia parvifolia. J Am Chem Soc, 1994. 116: p. 9337-9338.
13. Witherup, K.M., et al., Cyclopsychotride A, a biologically active, 31-residue cyclic peptide isolated from Psychotria longipes. J Nat Prod, 1994. 57(12): p. 1619-25.
14. Heitz, A., D. Le-Nguyen, and L. Chiche, Min-21 and min-23, the smallest peptides that fold like a cystine-stabitized beta-sheet motif: design, solution structure, and thermal stability. Biochemistry, 1999, 38(32): p. 10615-25.
15. Boulegue, C., Musiol, H.J., Prasad, V., Moroder, L., Synthesis of cysteine-rich peptides. Chemistry Today, 2006. 24(4): p. 24-36.
16. Korsinczky, M.L., H.J. Schirra, and D.J. Craik, Sunflower trypsin inhibitor-1. Curr Protein Pept Sci, 2004, 5(5): p. 351-64.
17. Mulvenna, J.C., David, Cybase: A database of cyclic proteins. 2004.
18. Yu Q, L.R., Tam JP, Engineered Salt-insensitive -Defensins with End-to-end Circularized Structures. J Biol Chem, 2000. 275: p. 3943-3949.
19. Simonsen, S.M., N.L. Daly, and D.J. Craik, Capped acyclic permutants of the circular protein kalata B1. FEBS Lett, 2004, 577(3): p. 399-402.
20. Craik DJ, D.N., Nielsen KJ, Cyclized conotoxin peptides, in University of Queensland. 2000: Australia.
21. Tarn JP, L.Y., Synthesis of Large Cyclic Cystine-Knot Peptide by Orthogonal Coupling Strategy Using Unprotected Peptide Precursors. Tetrahedron Letters, 1997. 38(32): p. 5599-5602.
22. Avrutina, O., Schmoldt, H.U., Kolmar, H., Diederichsen, U., Fmoc-Assisted Synthesis of a 29-Residue Cystine-Knot Trypsin Inhibitor Containing a Guaninyl Amino Acid at the Pl-Position. European Journal of Organic Chemistry, 2004. 2004(23): p. 4931-35.
23. Thongyoo, P., E.W, Tate, and R.J. Leatherbarrow, Total synthesis of the macrocyclic cysteine knot mieroprotein MCoTI-II. Chem Commun (Camb), 2006(27): p. 2848-50.
24. Jennings, C., et al., Biosynthesis and insecticidal properties of plant cyclotides: the cyclic knotted proteins from Oldenlandia affinis. Proc Natl Acad Sci USA, 2001. 98(19): p. 10614-9.
25. Gran, L., An oxytocic principle found in Oldenlandia affinis DC. An indigenous congolese drug "Kalata-Kalata" used to accelerate delivery. Medd Nor Farm Selsk, 1970. 32: p. 173-80.
26. Lindholm, P., et al., Cyclotides: a novel type of cytotoxic agents. Mol Cancer Ther, 2002. 1(6): p. 365-9.
27. Werle, M., et al., Evaluation and improvement of the properties of the novel cystine-knot microprotein McoEeTl for oral administration. Int J Pharm, 2007. 332(1-2): p. 72-9.
28. Reiss, S., et al., Inhibition of platelet aggregation by grafting RGD and KGD sequences on the structural scaffold of small disulfide-rich proteins. Platelets, 2006, 17(3): p. 153-7.
29. Krause, S., et al., Grafting of thrombopoietin-mimetic peptides into cystine knot miniproteins yields high-affinity thrombopoietin antagonists and agonists. Febs J, 2007. 274(1): p. 86-95.
30. Craik, D.J., S. Simonsen, and N.L. Daly, The cyclotides: novel macrocyclic peptides as scaffolds in drug design. Curr Opin Drug Discov Devel, 2002. 5(2): p. 251-60.